Riskpilot← Back to searchSign inGet full accessIMED ApS
APSActiveCVR 29929777Skovdalsvej 4Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20060 employees
Revenue 2024
DKK 869K
-5% vs 2023
EBITDA margin
100.0%
-5% vs 2023
Equity ratio
87.9%
Financial strength
Net profit 2024
DKK 664K
-14% vs 2023
| Revenue | DKK 869K | -5% |
| EBITDA | DKK 869K | -5% |
| Net profit | DKK 664K | -14% |
| Total assets | DKK 827K | -26% |
| Equity | DKK 727K | -16% |
| Employees | 0 | — |
Legal name
IMED ApS
CVR number
29929777
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
27. september 2006
Share capital
DKK 50.000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at udøve virksomhed med handel og industri og aktiviteter i tilknytning hertil
Address
Skovdalsvej 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 553 | 481 | 815 | 613 | 915 | 602 | 1.130 | 924 | 1.050 | 629 | 979 | 911 | 869 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 553 | 481 | 815 | 613 | 915 | 602 | 1.130 | 924 | 1.050 | 629 | 979 | 911 | 869 |
| Depreciation & amort. | -21 | -21 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 531 | 460 | 815 | 613 | 915 | 602 | 1.130 | 924 | 1.050 | 629 | 979 | 911 | 869 |
| Net financials | 1 | 1 | -141 | -98 | 30 | 21 | -215 | 47 | -41 | -57 | -104 | 82 | -14 |
| Profit before tax | 533 | 461 | 675 | 515 | 945 | 623 | 915 | 971 | 1.009 | 572 | 874 | 993 | 855 |
| Tax | 133 | 115 | 205 | 145 | 193 | 135 | 202 | 215 | 229 | 133 | 193 | 219 | 192 |
| Net profit | 399 | 345 | 470 | 370 | 752 | 488 | 713 | 756 | 780 | 439 | 682 | 773 | 664 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 713 | 631 | 560 | 805 | 1.061 | 676 | 953 | 1.033 | 1.135 | 702 | 1.026 | 1.117 | 827 |
| Equity | 545 | 491 | 395 | 505 | 812 | 540 | 768 | 814 | 845 | 584 | 766 | 864 | 727 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 162 | 140 | 165 | 300 | 249 | 137 | 185 | 219 | 290 | 118 | 261 | 253 | 100 |
| Total debt | 162 | 140 | 165 | 300 | 249 | 137 | 185 | 219 | 290 | 118 | 261 | 253 | 100 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
87.9%
This company
38.2%
Market median
+130% vs market
20122024
Return on equity
91.3%
This company
18.4%
Market median
+396% vs market
20122024
Net profit margin
76.4%
This company
8.1%
Market median
+843% vs market
20122024
Asset turnover
1.05×
This company
1.12×
Market median
+6% vs market
20122024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
UB Chief Executive Officer | Chief Executive Officer | 2006 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ninpet Holding ApS | Company | 50.0% | 50.0% | 2014 |
UKB HOLDING ApS | Company | 50.0% | 50.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
UKB HOLDING ApS
IMED ApS Board members of IMED ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrik Bruhn | Chief Executive Officer | 0 companies |